Determination of Risk Groups for the Covid-19 Underlying Deseases

For every disease, there is a certain set of genes whose mutations increase the risk of illness development. DNA sequencing of sick and healthy individuals results in the determination of genes related to certain diseases. Efficient procedures are described in order to determine point mutations in g...

Descripción completa

Detalles Bibliográficos
Autores principales: Vagis, A. A., Gupal, A. M., Sergienko, I. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012156/
https://www.ncbi.nlm.nih.gov/pubmed/33821122
http://dx.doi.org/10.1007/s10559-021-00347-9
_version_ 1783673322781802496
author Vagis, A. A.
Gupal, A. M.
Sergienko, I. V.
author_facet Vagis, A. A.
Gupal, A. M.
Sergienko, I. V.
author_sort Vagis, A. A.
collection PubMed
description For every disease, there is a certain set of genes whose mutations increase the risk of illness development. DNA sequencing of sick and healthy individuals results in the determination of genes related to certain diseases. Efficient procedures are described in order to determine point mutations in gene sequences of the examined patients. The optimal Bayesian procedure is used to determine risk groups for certain diseases, including the ones that underlie COVID-19.
format Online
Article
Text
id pubmed-8012156
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-80121562021-04-01 Determination of Risk Groups for the Covid-19 Underlying Deseases Vagis, A. A. Gupal, A. M. Sergienko, I. V. Cybern Syst Anal Article For every disease, there is a certain set of genes whose mutations increase the risk of illness development. DNA sequencing of sick and healthy individuals results in the determination of genes related to certain diseases. Efficient procedures are described in order to determine point mutations in gene sequences of the examined patients. The optimal Bayesian procedure is used to determine risk groups for certain diseases, including the ones that underlie COVID-19. Springer US 2021-04-01 2021 /pmc/articles/PMC8012156/ /pubmed/33821122 http://dx.doi.org/10.1007/s10559-021-00347-9 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Vagis, A. A.
Gupal, A. M.
Sergienko, I. V.
Determination of Risk Groups for the Covid-19 Underlying Deseases
title Determination of Risk Groups for the Covid-19 Underlying Deseases
title_full Determination of Risk Groups for the Covid-19 Underlying Deseases
title_fullStr Determination of Risk Groups for the Covid-19 Underlying Deseases
title_full_unstemmed Determination of Risk Groups for the Covid-19 Underlying Deseases
title_short Determination of Risk Groups for the Covid-19 Underlying Deseases
title_sort determination of risk groups for the covid-19 underlying deseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012156/
https://www.ncbi.nlm.nih.gov/pubmed/33821122
http://dx.doi.org/10.1007/s10559-021-00347-9
work_keys_str_mv AT vagisaa determinationofriskgroupsforthecovid19underlyingdeseases
AT gupalam determinationofriskgroupsforthecovid19underlyingdeseases
AT sergienkoiv determinationofriskgroupsforthecovid19underlyingdeseases

Ejemplares similares